TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
New findings reported from M.C. Arendrup and co-authors describe advances in life sciences
April 28th, 2009
"Caspofungin is used for the treatment of acute invasive candidiasis and as salvage treatment for invasive aspergillosis. We report characteristics of isolates of Candida albicans and Aspergillus fumigatus detected in a patient with breakthrough infection complicating severe gastrointestinal surgery and evaluate the capability of susceptibility methods to identify candin resistance," investigators in Copenhagen, Denmark report. "The susceptibility of C. albicans to caspofungin and anidulafungin was investigated by Etest, microdilution (European Committee on Antibiotic Susceptibility Testing [ EUCAST] and CLSI), disk diffusion, agar dilution, and FKS1 sequencing and in a...
Source: TB & Outbreaks Week (2009-04-28)
|
